Figure 3From: Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines Growth inhibition assay. Dasatinib showed minimal to modest activity against leiomyosarcoma cell lines. Maximal growth inhibitory effect for SK-UT-1 and SK-UT-1B was 42.8% and 55% respectively.Back to article page